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Résumé en
anglais
UNLABELLED: Lipid nanocapsules (LNCs) and lipid nanoemulsions (LNEs) are
biomimetic synthetic nanocarriers. Their in vitro and in vivo performance was
evaluated as a function of their size (25, 50 and 100 nm) and the surface PEG chain
length. Analysis methods included complement activation test, particle uptake in
macrophage and HEK293(β3) cells and biodistribution studies with tumor-grafted
mice by fluorescence imaging. A particular attention was paid to keep the
concentration of each nanocarrier and to the amount of fluorescent dye in
comparable conditions between the in vitro and in vivo studies. Under these
conditions, no significant differences were found among the three tested particle
sizes and the two nanocarrier types. Longer PEG chains on the LNE surface
provided better stealth properties, whereas PEG modification on the LNC
formulations inhibited the production of stable nanocarriers. Passive accumulation
of LNCs and LNEs in different tumor types depended on the degree of tumor
vascularization.
FROM THE CLINICAL EDITOR: This study of lipid nanocapsules and lipid
nanoemulsions compares their vitro and in vivo performance as a function of size
and surface PEG chain length, demonstrating no significant difference among the
tested particle sizes. Longer PEG chains on the LNE surface provided better stealth
properties, whereas PEG modification on the LNC formulations inhibited the
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